ANXA5 and neoplasm: For example, some studies have coupled doxorubicin with AnxA5, and its tumor-killing effect is stronger than that of either agent alone, suggesting that AnxA5 may enhance the antitumor effect of doxorubicin by targeting tumor vascular endothelial cells and tumor cells [112].